About NChroma Bio
NChroma Bio is a company based in San Diego (United States) founded in 2024. It operates as a B2B. NChroma Bio offers products and services including Epigenetic Editors, DLVR Particles, and CRMA-1001. NChroma Bio operates in a competitive market with competitors including Senti Biosciences, Beam Therapeutics, eGenesis, Korro Bio and Tenaya Therapeutics, among others.
- Headquarter San Diego, United States
- SectorsHealthcare
- Email••••••••
- Website nchromabio.com
- Social LinkedIn
Products & Services of NChroma Bio
NChroma Bio offers a comprehensive portfolio of products and services, including Epigenetic Editors, DLVR Particles, and CRMA-1001.
Enables gene regulation for lifelong cures without DNA changes
Facilitates targeted delivery of macromolecules for gene editing
Targets chronic hepatitis B and D for potential functional cures
Competitors of NChroma Bio
NChroma Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Senti Biosciences, Beam Therapeutics, eGenesis, Korro Bio and Tenaya Therapeutics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sentibio.com | 2016 | San Francisco, United States | $158M | – | Cell-based therapies for cancer treatment are developed. | |
| beamtx.com | 2017 | Cambridge, United States | $222M | 340 | Developer of gene therapy using CRISPR base editing to treat diseases | |
| egenesisbio.com | 2015 | Cambridge, United States | $481.42M | 94 | Gene transplantation platform for humanizing pig cells is developed. | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. | |
| tenayatherapeutics.com | 2016 | San Francisco, United States | $142M | 140 | Regenerative and gene therapeutics for heart failure are developed. | |
| eigerbio.com | 2000 | San Carlos, United States | $8.9M | 56 | Developer of antiviral agents against targets in the treatment of hepatitis | |
| metagenomi.co | 2016 | Berkeley, United States | $376.37M | – | Next-generation gene editing tools are developed for drug enhancement. | |
| primemedicine.com | 2019 | Cambridge, United States | $200M | 214 | Genetic therapies for diseases are developed using prime editing technology. | |
| scribetx.com | 2018 | Alameda, United States | $120M | – | A CRISPR-based gene-editing platform is developed for therapeutic applications. | |
| bluebirdbio.com | 1992 | Cambridge, United States | $210.68M | 508 | Gene therapies for severe genetic and rare diseases are developed. |
Detailed competitors of NChroma Bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of NChroma Bio
The website of NChroma Bio (nchromabio.com) receives about 3.3K visits a month.
- Monthly visits3.3K
▼ 45.9% vs previous month
Websites whose visitors overlap most with NChroma Bio. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| medtherapybiotech.com | 100% | 5.9K | #2,698,476 | View details | |
| keloniatx.com | 99% | 5.7K | #3,190,311 | View details | |
| marengotx.com | 96% | 3.3K | #5,030,761 | View details | |
| oxeiabiopharma.com | 96% | 3.3K | #5,389,668 | View details | |
| hcbioscience.com | 88% | – | – | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 10 similar websites and full traffic analytics for NChroma Bio
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to NChroma Bio
10 companies that operate in the same segment as NChroma Bio (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about NChroma Bio
NChroma Bio was founded in 2024.
NChroma Bio is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
nChroma Bio is a biotechnology company that develops genetic medicines by harnessing epigenetic editors and delivery technologies to address limitations in gene therapies. Their platform enables one-time cures without altering DNA sequences, targeting diseases like chronic hepatitis B and D. They conduct pre-clinical and clinical studies, collaborate with experts, and are based in Boston, MA, focusing on partnerships for broader therapeutic applications.
NChroma Bio's top competitors include eGenesis, Senti Biosciences and Korro Bio.
NChroma Bio offers Epigenetic Editors, DLVR Particles, and CRMA-1001.